Study | Cancer Type | 2 mg/kg Q3W | 10 mg/kg Q3W | 10 mg/kg Q2W | 200 mg Q3W |
---|---|---|---|---|---|
KEYNOTE-001 | Melanoma | 165 | 309 | 176 | |
KEYNOTE-001 | NSCLC | 61 | 288 | 204 | |
KEYNOTE-002 | Melanoma | 207 | 212 | ||
KEYNOTE-006 | Melanoma | 270 | 272 | ||
KEYNOTE-010 | NSCLC | 327 | 326 | ||
KEYNOTE-024 | NSCLC | 152 | |||
KEYNOTE-045 | Urothelial Cancer | 262 | |||
KEYNOTE-052 | Urothelial Cancer | 311 | |||
KEYNOTE-055 | HNSCC | 47 | |||
KEYNOTE-164 | MSI-H | 58 |
There are patients with missing indication for N = 24 from KEYNOTE-001, 002 and 006
NSCLC Non–Small Cell Lung Cancer, HNSCC Head and Neck Squamous Cell Carcinoma, MSI-H Microsatellite Instability-High Carcinoma